Literature DB >> 12667825

Lung development-the effects of chronic hypoxia.

Sheila G Haworth1, Alison A Hislop.   

Abstract

Chronic hypoxia compromises the development of both airways and pulmonary vasculature following exposure before or after birth. It also impairs adaptation to extrauterine life. The immediate morbidity and mortality is high, and long-term sequelae in terms of lung structure, and thus function, are common, particularly in premature infants. Chronic lung disease or bronchopulmonary dysplasia can develop with or without cor pulmonale. The extensive fibrotic disease of classical bronchopulmonary dysplasia has become uncommon with the development of improved treatment strategies, but the development of the lung periphery can still be compromised as more immature babies survive. This article highlights the landmarks of normal lung development together with the principal established and newly recognized features of exposure to chronic hypoxic in the young. In doing so, it indicates promising areas for research activity.

Entities:  

Mesh:

Year:  2003        PMID: 12667825     DOI: 10.1016/s1084-2756(02)00195-1

Source DB:  PubMed          Journal:  Semin Neonatol        ISSN: 1084-2756


  18 in total

1.  Smooth Muscle Insulin-Like Growth Factor-1 Mediates Hypoxia-Induced Pulmonary Hypertension in Neonatal Mice.

Authors:  Miranda Sun; Ramaswamy Ramchandran; Jiwang Chen; Qiwei Yang; J Usha Raj
Journal:  Am J Respir Cell Mol Biol       Date:  2016-12       Impact factor: 6.914

Review 2.  In Vitro Models to Study Human Lung Development, Disease and Homeostasis.

Authors:  Alyssa J Miller; Jason R Spence
Journal:  Physiology (Bethesda)       Date:  2017-05

3.  MiR-126a-5p is involved in the hypoxia-induced endothelial-to-mesenchymal transition of neonatal pulmonary hypertension.

Authors:  Yan-Ping Xu; Qi He; Zheng Shen; Xiao-Li Shu; Chen-Hong Wang; Jia-Jun Zhu; Li-Ping Shi; Li-Zhong Du
Journal:  Hypertens Res       Date:  2017-02-02       Impact factor: 3.872

4.  Hypoxic stress exacerbates hyperoxia-induced lung injury in a neonatal mouse model of bronchopulmonary dysplasia.

Authors:  Veniamin Ratner; Siarhei Slinko; Irina Utkina-Sosunova; Anatoly Starkov; Richard A Polin; Vadim S Ten
Journal:  Neonatology       Date:  2008-12-04       Impact factor: 4.035

5.  Morphological optimization for access to dual oxidants in biofilms.

Authors:  Christopher P Kempes; Chinweike Okegbe; Zwoisaint Mears-Clarke; Michael J Follows; Lars E P Dietrich
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-12       Impact factor: 11.205

6.  Enhanced NO-dependent pulmonary vasodilation limits increased vasoconstrictor sensitivity in neonatal chronic hypoxia.

Authors:  Joshua R Sheak; Laura Weise-Cross; Ray J deKay; Benjimen R Walker; Nikki L Jernigan; Thomas C Resta
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-07-21       Impact factor: 4.733

7.  Effects of a superoxide dismutase mimetic on biomarkers of lung angiogenesis and alveolarization during hyperoxia with intermittent hypoxia.

Authors:  Michael Chang; Fayez Bany-Mohammed; M Cristina Kenney; Kay D Beharry
Journal:  Am J Transl Res       Date:  2013-09-25       Impact factor: 4.060

8.  Inhibition of the SDF-1/CXCR4 axis attenuates neonatal hypoxia-induced pulmonary hypertension.

Authors:  Karen C Young; Eneida Torres; Konstantinos E Hatzistergos; Dorothy Hehre; Cleide Suguihara; Joshua M Hare
Journal:  Circ Res       Date:  2009-05-07       Impact factor: 17.367

9.  Transforming growth factor-beta signaling mediates hypoxia-induced pulmonary arterial remodeling and inhibition of alveolar development in newborn mouse lung.

Authors:  Namasivayam Ambalavanan; Teodora Nicola; James Hagood; Arlene Bulger; Rosa Serra; Joanne Murphy-Ullrich; Suzanne Oparil; Yiu-Fai Chen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-05-16       Impact factor: 5.464

10.  The pulmonary surfactant: impact of tobacco smoke and related compounds on surfactant and lung development.

Authors:  J Elliott Scott
Journal:  Tob Induc Dis       Date:  2004-03-15       Impact factor: 2.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.